Mode
Text Size
Log in / Sign up
N/A N=99 Randomized Prevention

Safety and Effectiveness of an Auricular Spray

Excessive Ear Wax

Enrolled (actual)
99
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Skin Irritation — 0.22; 0.20; 0.13; 0.11 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Ear Hygiene (Other)
Age
Pediatric, Adult, Older Adult · 3+ yrs
Sex
All
Sponsor
YSLab
Primary completion
Jul 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Skin Irritation
0.22; 0.20; 0.13; 0.11
SECONDARY
Ear Canal Obstruction Due to Excessive Earwax
2.33; 2.29; 1.19; 1.97
SECONDARY
Hearing Function
1.07; 0.26

Summary

The goal of this clinical trial is to test the safety and efficacy of a medical device in subjects with cerumen in excess. The main questions it aims to answer are: * Does the medical device induce skin irritation in the ear canal? * Does the medical device reduce obstruction of ear canal induced by excessive cerumen? Participants will use the device in each ear, once a day, every 3 days at home. Researchers will compare the medical device group to a control group who will not use the medical device.

Eligibility Criteria

Inclusion Criteria

  • Gender: female and/or male.
  • Age:

30 to 40% having age between 3 to 12 yo, 30 to 40% between 13 to 65 yo, 30 to 40% more than 65 yo.

  • Subjects able to use the tested product.
  • Subjects having history of cerumen occlusion more than once a year with or without symptoms (reduction of hearing function, obstruction feeling of the ear canal,..).
  • Subjects having ear help system or regular users of systems such as anti-noise plugs or headsets (only for the 13yo subjects and more).
  • Subjects having a clinical score of ear canal obstruction of 2 or 3 at D0.

Exclusion Criteria

  • Subjects who had chirurgical act on the mastoïde.
  • Subjects who had severe troubles of the internal ear (severe dizziness, desorientation, nausea).
  • Subjects using regularly a ear spray for washing his/her ears.
  • Subjects having a score of ear canal obstruction at 4 at D0.
  • Pregnant or nursing woman or planning a pregnancy during the study;
  • Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship;
  • Subject in a social or sanitary establishment;
  • Subject suspected to be non-compliant according to the investigator's judgment;
  • Subject with a condition or receiving a medication which, in the investigator's judgment, put the subject at undue risk;
  • Subject suffering from a severe or progressive disease.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06085443). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search